Your browser doesn't support javascript.
loading
Navigating the path of progress: The OMERACT 2023 emerging leaders program.
Campbell, T Mark; Finzel, Stephanie; Siddle, Heidi; Christensen, Robin; Nielsen, Sabrina Mai; Najm, Aurelie; Otobo, Tarimobo M; Sahbudin, Ilfita; Sinnathurai, Premarani; Stok, Kathryn S; Touma, Zahi; April, Karine Toupin; Grosskleg, Shawna; Tugwell, Peter; Richards, Bethan.
Afiliação
  • Campbell TM; Elisabeth Bruyère Hospital, Ottawa, ON, Canada; Bone and Joint Research Lab, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. Electronic address: tcampbell@bruyere.org.
  • Finzel S; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Siddle H; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Christensen R; Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
  • Nielsen SM; Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
  • Najm A; School of Infection & Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Otobo TM; Department of Medical Imaging, Temerty Faculty of Medicine, University of Toronto, 263 McCaul Street 4th Floor, Toronto, Ontario M5T 1W7, Canada.
  • Sahbudin I; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and Institute for Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
  • Sinnathurai P; Department of Rheumatology, Royal North Shore Hospital, Sydney NSW Australia; Sydney Musculoskeletal Health, University of Sydney, Sydney NSW Australia.
  • Stok KS; Department of Biomedical Engineering, The University of Melbourne, Melbourne, Australia.
  • Touma Z; University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.
  • April KT; School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada; Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada; Institut du savoir Montfort, Ottawa, Ca
  • Grosskleg S; OMERACT, Toronto, Canada and Faculty of Medicine, University of Ottawa, Ottawa, Canada.
  • Tugwell P; University of Ottawa, Department of Medicine, Faculty of Medicine, K1H 8M5, Ottawa, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, K1Y 4E9, Ottawa, Canada; University of Ottawa, School of Epidemiology and Public Health, Faculty of Medicine, K1H 8M5, Ottawa, Canada; WHO Co
  • Richards B; Department of Rheumatology, Royal Prince Alfred Hospital, Australia; Institute for Musculoskeletal Health, Sydney Local Health District, Australia; Sydney Musculoskeletal Health, University of Sydney, Australia.
Semin Arthritis Rheum ; 66: 152414, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38447468
ABSTRACT

OBJECTIVES:

The Outcome Measures in Rheumatology Clinical Trials (OMERACT) Emerging Leaders Program (ELP) aims to cultivate a cohort of skilled leaders within the OMERACT community empowering them with expertise and knowledge to help shape and steer the organization into the future. This publication highlights the significance of the ELP in driving leadership excellence, its impact on OMERACT's evolution, and the outcomes and learnings from the OMERACT 2023 ELP.

METHODS:

Insights from the 2018 ELP report informed 2023 program improvements. Engagement was measured by attendance and WhatsApp interactions. Positive program aspects, areas for improvement and ideas for enhancing future ELPs were captured via anonymous survey and participant focus groups.

RESULTS:

Engagement with the ELP was high with 9 participants, 96 % attendance at all workshops, 154 WhatsApp interactions. All program components were highly rated, with the highest being the 'Psychological Safety' and 'Methodology/Process/Politics' workshops. Future enhancements included creating further networking, connection and support activities, practical leadership and methodological skill development opportunities, and a new stream focussing on organisational advancement.

CONCLUSIONS:

The 2023 OMERACT ELP was well received and successfully addressed areas previously identified as requiring improvement. New educational enhancements were valued, and the importance of fostering psychological safety at all levels was highlighted. The ELP fortifies OMERACT by nurturing a diverse array of skilled leaders who embody OMERACTs core values. Continuing to refine and evolve the ELP over time will help OMERACT sustain its global influence in patient-centered outcome research.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Liderança Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Liderança Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article